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Abstract
Supervised machine learning can precisely identify different cancer tumors at any stage by classifying cancerous
and healthy samples based on their genomic profile. We have developed novel methods of MLAC (Machine
Learning Against Cancer) achieving perfect results with perfect precision, sensitivity and specificity. We have
used the whole genome sequencing data acquired by next generation RNA sequencing techniques in The Cancer
Genome Atlas and Genotype-Tissue Expression projects for cancerous and healthy tissues respectively. Indeed,
a creative way to work with data and general algorithms has resulted in perfect classification i.e. all precision,
sensitivity and specificity are equal to 1 for most of different tumor types even with modest amount of data. Our
system can be used in practice because once the classifier is trained, it can be used to classify any new sample
of new potential patients. One advantage of our work is that the aforementioned perfect precision and recall
are obtained on samples of all stages including very early stages of cancer; therefore, it is a promising tool for
diagnosis of cancers in early stages. Another advantage of our novel model is that it works with normalized values
of RNA sequencing data, hence people’s private sensitive medical data will remain hidden, protected and safe.
This type of analysis will be widespread and economical in the future and people can even learn to receive their
RNA sequencing data and do their own preliminary cancer studies themselves which has the potential to help the
healthcare systems.
1. Introduction
Cancer is one of the most common risk factors that threatens people’s lives and is still a severe
unsolved problem as one of the main leading causes of death [13]. Early diagnosis plays a
vital role in cancer treatment and survival. There are dozens of different types of cancers
affecting different organs of body because cancer can start at any part of the body. [14] In
fact, cancer starts when cells in the body begin to grow out of control and is usually caused by
genetic mutations in different cells. Yet the main underlying reasons that cause these mutations
are unknown. In recent years, along with generation of big data by high throughput omics
technologies, applications of ML (Machine Learning) in diagnosis, treatment and prognosis of
cancers are hot topics of research. Consequently, computers have turned out to be promising
tools and reliable assistants to contribute in new discoveries based on analysis of the big data
generated by high throughput technologies. In this work, we have proposed a novel approach
to use genetic transcriptomic data leading to great results with perfectly accurate distinguish
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between WES (Whole Exome Sequencing) RNA profiles of 22 different main cancers from TCGA
(The Cancer Genome Atlas), [15] and their corresponding healthy tissue samples from GTEx
(Genotype-Tissue Expression) project [16] with samples from different numbers of people as
illustrated in Table 1.
Table 1 also contains reported numbers of estimated new cases and estimated deaths because
of each cancer out of estimated 1806590 new cases of all cancers with estimated 606520 new
deaths in 2020 in the U.S. for instance.[1] Reusability and transfer learning are among the main
advantageous of ML that means once a machine is well-trained and could distinguish cancerous
from noncancerous tissues, it can be fed by new data of new samples acquired from new people
and the new sample will be classified correctly with a high likelihood. Therefore, the utilization
of ML systems that can detect cancerous genome even at the earliest stages by NGS (Next
Generation Sequencing) technology is likely to be a killer application.
TCGA abbr. Cancer (TCGA) Organ (Gtex) #Cancer #Healthy New Cases Deaths
ACC Adrenocortical Carcinoma Adrenal Gland 77 128 - -
BLCA Bladder Carcinoma Bladder 407 9 81400 17980
LGG Lower Grade Glioma Brain (Nerves) 508 1152 23890 18020
BRCA Breast invasive Carcinoma Breast 1091 179 279100 42690
CESC Cervical cancers Cervix 304 10 13800 4290
LAML Acute Myeloid Leukemia Bone Marrow 173 70 6150 1520
COAD Colon Adenocarcinoma Colon 286 308 104610 53200
ESCA Esophageal Carcinoma Esophagus 181 653 18440 16170
GBM Glioblastoma Multiforme Brain 518 1152 incl. Brain @ LGG
KIRC Kidney Renal Clear Cell Kidney (Pelvis) 530 28 73750 14830
LIHC Liver Hepatocell. Carci. Liver (& bile duct) 369 110 42810 30160
LUAD Lung Adenocarcinoma Lung (& bronchus) 513 288 228820 135720
LUSC Lung Squamous Cell Lung (& bronchus) 498 288 incl. Lung @LUAD
OV Ovarian cystadenocarci. Ovary (Serous) 420 88 21750 13940
PAAD Pancreatic Adenocarci. Pancreas 178 167 57600 47050
PRAD Prostate Adenocarci. Prostate 495 100 191930 33330
READ Rectum Adenocarci. Colon 91 308 43340 @COAD
SKCM Skin Cutaneous Melanoma Skin 102 812 108420 11480
STAD Stomach Adenocarcinoma Stomach 414 174 27600 11010
TGCT Testicular Germ Cell Tumors Testes 132 165 9610 440
THCA Thyroid Carcinoma Thyroid 504 279 52890 2180
UCEC Uterine Endometrial Carci. Uterus (Corpus) 180 78 65620 12590
Table 1: Number of samples of cancerous and healthy tissues obtained from TCGA and Gtex
plus estimated number of new cases and deaths of corresponding cancer in 2020 in the US.
2. Methods
ML and AI (Artificial Intelligence) is rapidly opening their positions in medical and pharmaceutical
sciences. Different models of ML have been tested successfully in recent years in many projects
as well as in this work and have returned decent results. Na¨ıve Bayes, Support Vector Machines,
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Decision Trees, Random Forest, Logistic Regression and K Nearest Neighbors are examples of
general supervised ML algorithms that have reportedly given great results in different projects in
different fields of science and are analyzed in our project too. In addition to them, an unsupervised
ML method i.e. K-Means is also tested. In this work we came up with a practical approach of
applying ML for cancer diagnosis that is effective and robust in different ML algorithms we have
tried. Since they are most well-known common ML algorithms, we will briefly introduce them in
the following paragraphs. On the other hand, the WES genetic information obtained by NGS are
openly available on TCGA, Gtex and other online public databases. However, we do not review
the technical details of RNA sequencing techniques because they are out of scope of the current
paper. The focus of our work in this article is to receive the data from two aforementioned open
databases, train the ML classifiers with them, and validate them. To do it, we have used the
following ML techniques:
2.1 Naive Bayesian classifiers
Bayes’ theorem was proposed by the English Thomas Bayes in 1763 when he was trying to prove
the existence of God by means of statistical inference. [7] Bayesian statistics are used in estimates
based on anticipated subjective knowledge. Therefore, the implementations of this theorem adapt
with use and allow combining the fusion of data from two or more different sources and expressing
them in terms of likelihood. Naive Bayesian Classifier is an implementation of Bayes’ theorem,
with some additional simplifying hypotheses, which allow applying an independence hypothesis,
between the predictor variables, hence ”Naive” is added to the name of these implementations
because a naive Bayesian classifier assumes that the features of a class / object are not related
to each other i.e. the presence of a particular feature is not related to the presence or absence
of another. In this way each feature independently contributes to the probability of a given
class. In return, Bayes Classifiers can easily be trained, require little data to train, and can
classify big data quickly. Despite the fact that naive Bayes classifiers are amazingly simple, they
have worked quite well in many real-world situations, including our cancerous/healthy tissue
classification. Our naive Bayes classifier requires a small amount of training data and is fast and
accurate as reflected in the Results section. On the flip side, although naive Bayes is known
as a decent classifier, it is known to be a bad estimator in a sense that one cannot rely on its
parameters for extraction of feature importance. [9]
2.1.1 Bayesian model function
More formally, as shown by equations 1-6, Bayesian classifiers are, indeed, probabilistic classifiers
using Bayes rule i.e.
P (A | B) = P (A)P (B | A)/P (B) (1)
For example, A can be the prior probability of cancer and B the posterior probability of cancer;
given positive cancer test result is the product of the prior times the sensitivity i.e. the chance
of a positive result given cancer. Indeed, a naive Bayesian classifier accomplishes statistical
inference based on maximum likelihood estimation i.e. setting the parameters of the probability
distribution in a way that maximises the goodness of fit of a statistical model to the training
data via joint probability distributions of the training samples. In technical words, the likelihood
function describes a hyper surface whose peak, if it exists, is an arrangement of model parameters
values and coefficients that maximize the probability of drawing the obtained sample. [8] In its
more general form, according to Sci-kit Learn website documentation, Bayes’ theorem states the
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following relationship, given class variable y and dependent feature vector x1 through xn:
P (y | x1, . . . , xn) = P (y)P (x1, . . . , xn | y)
P (x1, . . . , xn)
(2)
Using the naive conditional independence assumption that
P (xi|y, x1, . . . , xi−1, xi+1, . . . , xn) = P (xi|y) (3)
for all i, this relationship is simplified to
P (y | x1, . . . , xn) = P (y)
∏n
i=1 P (xi | y)
P (x1, . . . , xn)
(4)
Since P (x1, x2, ..., xn) is constant given the input, we can use the following classification rule:
P (y | x1, . . . , xn) ∝ P (y)
n∏
i=1
P (xi | y) => yˆ = argmax
y
P (y)
n∏
i=1
P (xi | y) (5)
We can use MAP (Maximum A Posteriori) estimation to estimate P (y) and P (xi | y); the
former is then the relative frequency of class in the training set. The different naive Bayes
classifiers differ mainly by the assumptions they make regarding the distribution of P (xi | y).
[9] GaussianNB implements the Gaussian Naive Bayes algorithm for classification. Thus, the
likelihood of the features is assumed to be Gaussian:
P (xi | y) = 1√
2piσ2y
exp
(
− (xi − µy)
2
2σ2y
)
(6)
where the parameters σy and µy are estimated using maximum likelihood.
2.2 Support vector machines
Support Vector Machines (SVMs) are a set of supervised learning algorithms developed by
Vladimir Vapnik and his team at AT&T Labs. [17, 18, 19] These methods are related to both
classification and regression problems. In classification, given a set of sample training examples,
we can label the classes and train an SVM to build a model that predicts the class of a new
sample. Intuitively, an SVM is a model that represents the sample points in space, separating
the classes into spaces as distant as possible using a separation hyperplane defined as the vector
between the two points, of the two classes, closest to the which is called the support vector.
When the new samples are put before the model, depending on the spaces to which they belong,
they can be classified into the right class.
2.2.1 SVM Model function
More formally, an SVM builds a set of hyperplanes [20] in a very high (or even infinite) dimen-
sional space that can be used in classification or regression problems. A good separation between
the classes will allow a correct classification. In this concept of optimal separation is where the
fundamental characteristic of SVM resides: this type of algorithms search for the hyperplane
that has the maximum distance (margin) with the points that are the closest to it. This is why
SVMs are also sometimes referred to as maximum margin classifiers. In this way, the points of
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Figure 1: Svm separating hyperplanes, from article ”Support vector machine”. In Wikipedia
(2012). Accessed June 27, 2020.
the vector that are labeled with one category will be on one side of the hyperplane and the cases
that are in the other category will be on the other side. SVM algorithms intrinsically belong
to the family of linear classifiers. The vector formed by the points closest to the hyperplane is
called the support vector. Using tricks such as kernel functions, SVMs can also be an alternative
training method for polynomial classifiers, radial base functions, and multilayer perceptron neural
networks. Figure 1 illustrates SVM mechanism.
2.3 Decision trees
A decision tree is a tree-like map of the possible outcomes of a series of decisions and only
contains conditional control statements comparing possible actions with each other according to
their costs, probabilities and utilities. The goal of a decision tree is to break down all the available
visit data that a system can learn from and group it so that each group’s visits are as similar
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to each other as possible with respect to the goal metric. Between groups, however, visits are
as different as possible relative to the goal metric (for example, conversion rate). The decision
tree takes into account the different variables existing in the training set to determine how to
divide the data MECE (mutually exclusive, collectively exhaustive) into these groups or leaves to
maximize the goal. A decision tree typically starts with a single node and then branches out into
possible outcomes. Each of the outcome nodes creates additional nodes, which branch into other
different possibilities. This creates a structure similar to that of a tree. There are three different
types of nodes: probability nodes, decision nodes, and terminal nodes. A chance node,typically
represented by a circle, shows the probabilities of certain outcomes. A decision node,typically
represented by a square, shows a decision to be made, and a terminal node,typically represented
by a triangle, shows the final result of a decision route. Decision trees are still popular for
advantages such as requiring minimal data processing and being easily understood, updated,
(new options can be added to existing trees), and integrated with other decision-making tools.
However, decision trees can become very complex. In those cases, a more compact influence
diagram can be a good alternative focusing on fundamental goals, inputs, and decisions. [21]
2.4 Random forests
By iteratively applying the algorithm that creates decision trees with different parameters on the
same data, we get what is called a random forest. This algorithm is one of the most efficient
prediction methods for big data, since it averages the performance of many different models with
noise and impartially reduces the final variability of the set. In reality, what is done is to build
different training and test sets on the same data, which generates different decision trees on the
same data. The union of these trees of different complexities and with data of different origin,
although from the same set, results in a fairly stable random forest whose main characteristic
is that it creates more robust models than what could be obtained by creating a single decision
tree on the same data. In classification, the class that is the mode of classes will be output.
[22, 23]
2.5 Binary logistic regression
Logistic regression is a group of statistical techniques that aim to test hypotheses or causal
relationships when the dependent variable is nominal. Despite its name, it is not an algorithm
applied in regression problems, in which continuous values are dealt with, but it is a method for
classification problems, in which a binary value i.e. either 0 or 1 is obtained. For example, a
classification problem is to identify if a given tumor is malignant or benign. With the logistic
regression, the relationship between the dependent variable i.e. the statement to be predicted,
with one or more independent variables i.e. the set of features available for the model is deter-
mined. To do this, it uses a logistic function that determines the probability of the dependent
variable. As previously mentioned, what is sought in these problems is a classification, so the
probability must be translated into binary values for which a threshold value is used. If the prob-
ability values were above the threshold value, the statement is true and vice versa. Generally this
value is 0.5, although it can be increased or decreased to manage the number of false positives
or false negatives. [24]
The function that relates the dependent variable to the independent ones is also usually either
the sigmoid function or a function similar to it such as tanh and softmax. The sigmoid function
is an S-shaped curve that can take any value between 0 and 1, but never values outside these
6
Figure 2: Sigmoid function as the logistic curve
limits. The equation that defines the sigmoid function is f(x) = 1/(1 + e−x) where x is a real
number. In the equation you can see that when x tends to minus infinity the function tends
to zero. On the other hand, when x tends to infinity the function tends to unity. Figure 2
shows a graphical representation of the logistic function (sigmoid function). Logistic regression
is a technique widely used because of its effectiveness and simplicity. As one of its advantages,
it is not necessary to have large computational resources, neither in training nor in execution.
Furthermore, the results are highly interpretable that is one of its main advantages. The weight
of each of the features determines the importance it has in the final decision. Therefore, it
can be affirmed that the model has made one decision or another based on the existence of
one or another certain feature. What in many applications is highly desired in addition to
the model itself. Regarding its disadvantages is the impossibility of directly solving non-linear
problems because the expression that makes the decision is linear. For example, in the event
that the probability of a class is initially reduced with a feature and subsequently increased, it
cannot be registered with a logistic model directly. If necessary, this feature should previously be
transformed so that the model can record this non-linear behavior. In these cases, it is better to
use other models such as decision trees. Indeed, the important point is that the target variable
must be linearly separable. Otherwise, the logistic regression model will not classify correctly. In
other words, there must be two ”regions” with a linear border in the data. Another drawback
is the dependency it shows on the features. Logistic regression is not one of the most powerful
algorithms that exist. It would easily be surpassed by other more complex classifiers. Finally,
in machine learning, there are classifiers that can work with multiple classes, such as Decision
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Trees or Random Forest. On the other hand, there are others that do not, such as Logistic
Regression. However, it is always possible to use tricks to use logistic regression in classification
problems with multiple classes such as:
• OvA (One versus all): In this strategy, you have to train as many binary classifiers as possible
with respect to the classes that are there in the data set. Each of the models predicts the
probability that the record belongs to a class. When making a prediction, all classifiers are run
and the one with the highest probability is selected.
• OvO (One versus one): In this strategy, as many models are created as there are pairs of
possible outcomes, that is, they have to be trained (N2−N)/2 models, where N is the number
of possible classes. It means that a classifier will decide only between two possible outcomes.
As in the previous case, when making a prediction, all classifiers are run and the one with the
highest probability is selected.
2.6 K Nearest Neighbors
K-Nearest-Neighbor is a simple nonparametric instance-based algorithm of supervised ML. It
can be used to classify new samples (discrete values) or to predict (regression, continuous
values). It is essentially used to classify values by searching for the most similar (by proximity)
data points learned in the training stage and making guesses of new points based on the prior
classification. [25, 26] Unlike K-means, which is an unsupervised algorithm where the ”K”
means the number of groups that we want to classify, in K-Nearest Neighbor the ”K” means the
number of ”neighboring points” that we consider in the vicinity to classify the ”n” groups which
are already known in advance. It is a method that simply searches the closest observations to
the the point of interest that is to be classified and classifies it based on most of the data that
surrounds it. As we said before, K nearest neighbor algorithm is:
• Supervised: that means that we have tagged our training data set, with the class or expected
results.
• Instance-based: that means that our algorithm does not explicitly learn a model (such as in
Logistic Regression or Decision Trees). Instead, it memorizes the training instances that are used
as the knowledge-base for the prediction phase.
KNN is easy to learn and implement. However, it uses the entire data set to train each point
and therefore requires a lot of memory and processing resources. For these reasons KNN tends
to work best on small data sets and without a huge number of features. To classify the inputs
by means of KNN one should:
1. Calculate the distance between the item to classify and the other items in the training data
set. 2. Select the closest ”K” elements (with less distance, depending on the function used).
3. Carry out a majority vote between K points: those of a class / label that will be determinant
in making the final decision.
Taking point 3 into account, we will see that in order to decide the class of a point, the value of
K is very important because it defines which are the points their majority will define the group
each new point belongs to, and it is especially critical when the new points fall in the borders
between groups.
2.7 K-Means
K-Means is an unsupervised ML algorithm for clustering. It is used when we have a lot of un-
tagged data. The objective of this algorithm is to find K groups (clusters) among the raw data.
The algorithm works iteratively to assign each input such as genome sample to one of the K
8
groups based on its features, in here genes. It means that the inputs are grouped based on the
similarity of their features. [27] As a result of executing the algorithm:
• The centroids i.e. geometric centers of groups will be coordinates of the corresponding K
clusters and will be used to label new samples.
• Labels for the training data set: each tag belonging to one of the K defined groups.
The groups are defined dynamically i.e. their position is adjusted in each iteration of the process
until the algorithm would converge. Once the centroids are found, they are analyzed to see
what their unique features are, compared to those of the other groups. These groups are the
labels that the algorithm generates. The Clustering K-means algorithm is one of the most used
methods to find hidden groups or theoretically suspected groups on an unlabeled data set. This
can serve to confirm or reject some hypotheses that we would have assumed about our data,
and it can also help to discover hidden relationships between data sets. Once the algorithm
has executed and obtained the labels, it will be easy to classify new values or samples among
the obtained groups. This algorithm works by pre-selecting a value of K. To find the number
of clusters in the data, we must run the algorithm for a range of K values, see the results and
compare characteristics of the groups obtained. In general, currently there is no exact way to
determine the K value, but it can be estimated with acceptable precision using the following
technique: One of the metrics used to compare results is the average distance between the data
points and their centroid. As long as the value of the mean will decrease as we increase the
value of K, we will continue increasing it. The mean distance to the centroid is considered as a
function of K and the goal is to find the elbow point where the rate of descent sharpens.
In ML supervised classification methods as well as in K-Means unsupervised clustering algorithm,
the input data (the samples) are viewed as a p-dimensional vector (an array or ordered list of p
numbers where p in this project is 19627). Then the classifiers based on their criteria distinguish
among different groups formed by close/similar samples; e.g. in the Bayesian classifiers, the
classifier looks for a hypersurface that maximizes the likelihood of drawing the sample, or in
SVMs, it looks for a hyperplane that optimally separates the points of one class from the other,
which eventually could have been previously projected to a higher dimensional space. There has
been wrong perceptions in the ML community preventing potential achievements; for instance,
people try to decrease the number of features to avoid ”the curse of dimensionality”. While
the curse of dimensionality may truly happen in some problems, it may not be an issue in other
problems such as ours. Deleting features blindly for fear of dimensionality may only result in losing
useful information without need. Researchers usually try to reduce by themselves the assumed
learning pressure on the machines brought about by highly redundant dimensions and select a
subset of features i.e. genes to reduce the number of features and dimensions. [10, 11, 12] It
may have hurt their results. A strength point of our work is that we consider ML as powerful
advanced statistics tool doing heavy statistical analyses, that people themselves cannot do. As
a result, we gave all the data corresponding to the WES as feature inputs to the ML at once
and it returned almost perfect results quickly and precisely. We thought of 19627 different genes
not as too many features but as different pixels of a less than 141*141-pixel photo and it was a
very light task for the machine to analyze such a low resolution image and it took only seconds
to classify the cancerous and noncancerous cells 100% precisely.
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2.8 Model optimization and settings
We have employed all the classifiers from Scikit-Learn 0.23.1 with their default settings unless
mentioned otherwise. For example, Scikit-Learn’s Gaussian Naive Bayes classifier, that is a
simple classifier, has only two parameters i.e. priors equal to None and var smoothing equal to
1e-9 where var smoothing is the portion of the largest variance of all features that is added to
variances for calculation stability. We did not touch the defaults, but there were exceptions such
as SVM in which we changed two default settings: we decided to use ”linear” kernel instead of
”rbf” that was the default kernel and also we set ”PROBABILITY = TRUE” in order to obtain
”predict proba” that is a useful attribute to calculate and plot the ROC curve but is ignored in
default setting when ”PROBABILITY = FALSE”. Therefore, except these two minor changes
at SVM default settings, all models were run with default settings of Scikit-Learn version o.23.
As other settings, for most of the cancers, 90% specific cancer samples were used as the training
dataset and the remaining 10% used as testing dataset chosen by random using train test split
function of Sci-Kit Learn model selection modul with Random Seed equal to zero. The only
exceptions were for bladder and cervix for which the number of healthy samples was too low.
Therefore, we used 40% for training and 60% for testing in bladder and 70% for training and
30% for testing in cervix cancer. However, we analyzed the effect of different data allocation
plans from 10% to 90% for test/validation set and also tried other random seeds and in particular
for K Nearest Neighbor algorithm, we also tried it with different K values. The results were not
significantly different and discussed more in the following at the Discussion part of this article.
We also decided to mostly publish the results achieved by those classifiers that can do the
classification perfectly; however, all six classifiers work well and the imperfect ones also return
results close to perfect. The models take 19627-genes WES data as input and after a quick
and easy model training with no need to data modification, acceptable classification results are
obtained and there are at least two classifiers per cancer that could distinguish both cancerous
and healthy tissues perfectly with no error.
2.9 Model evaluation
Model evaluation produces measures to approximate a classifier’s reliability. To distinguish be-
tween cancerous and noncancerous cells, since it is a binary classification, we use accuracy,
precision, specificity, sensitivity, f1 score, several averaging techniques and ROC curve to evalu-
ate the model. We, indeed, use Sci-kit Learn Metrics Classification Report that returns precision,
recall and f1 score for each of two classes. In binary classification, recall of the positive class is
called “sensitivity”; and recall of the negative class is “specificity”. In what follows, the principal
terms and then equations7-22 derivations based on confusion matrix such as accuracy, specificity,
sensitivity, f1 score are given to review and compare:
• Condition positive (P): the number of real positive cases in the data
• Condition negative (N): the number of real negative cases in the data
• True positive (TP) or hit
• True negative (TN) or correct rejection
• False positive (FP), false alarm or type I error
• False negative (FN), miss or type II error
Sensitivity, recall, hit rate, or true positive rate (TPR):
TPR = TP/P = TP/(TP + FN) = 1− FNR (7)
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Specificity, selectivity or true negative rate (TNR):
TNR = TN/N = TN/(TN + FP ) = 1− FPR (8)
Precision or positive predictive value (PPV) is the ratio of the correctly labeled samples by our
program to all labeled ones in reality.
PPV = TP/(TP + FP ) = 1− FDR (9)
Precision can be calculated only for the positive class i.e. class 1 that shows cancer or can be
evaluated for each one of the two classes independently treating each class as it is the positive
class at time, and the latter is done in Sci-kit Learn Metrics Classification Report as shown in
table 1.
Negative predictive value (NPV):
NPV = TN/(TN + FN) = 1− FOR (10)
Miss rate or false negative rate (FNR):
FNR = FN/P = FN/(FN + TP ) = 1− TPR (11)
Fall-out or false positive rate (FPR):
FPR = FP/N = FP/(FP + TN) = 1− TNR (12)
False discovery rate (FDR):
FDR = FP/(FP + TP ) = 1− PPV (13)
False omission rate (FOR):
FOR = FN/(FN + TN) = 1−NPV (14)
Accuracy (ACC):
ACC = (TP + TN)/(T +N) = (TP + TN)/(TP + TN + FP + FN) (15)
The harmonic mean of precision and sensitivity or f1-score (F1):
F1 = 2.PPV.TPR/(PPV + TPR) = 2.TP/(2.TP + FP + FN) (16)
Since we are using Sci-kit Learn Metrics Classification Report to show the results as shown in ta-
ble 1, we also describe the meaning of micro avg, macro avg and weighted avg. used in the report:
Micro-average of precision (MIAP):
MIAP = (TP1 + TP2)/(TP1 + TP2 + FP1 + FP2) (17)
Micro-average of recall (MIAR):
MIAR = (TP1 + TP2)/(TP1 + TP2 + FN1 + FN2) (18)
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Micro-average of f-Score (MIAF) would be the harmonic mean of the two numbers above.
MIAF = 2.MIAP.MIAR/(MIAP +MIAR) (19)
Macro-average of precision (MAAP):
MAAP = (Precision1 + Precision2)/2 (20)
Macro-average of recall (MAAR):
MAAR = (Recall1 +Recall2)/2 (21)
Macro-average of f-Score (MAAF) would be the harmonic mean of the two numbers above.
MAAF = 2.MAAP.MAAR/(MAAP +MAAR) (22)
Macro-average is suitable to know how the system performs overall across different sets of data
but should not be considered in any specific decision-making because it calculates metrics for
each label and finds their unweighted mean i.e. it does not take label imbalance into account,
while in our case, the labels are highly imbalanced in many sets e.g. 1091 vs. 179. On the other
hand, micro-average is a useful tool and returns measures for our decision-makings especially
when coupled healthy-cancerous datasets vary in size because it calculates metrics globally by
counts the total true positives, false negatives and false positives. Finally, Weighted-average,
according to Sci-kit Learn documentation on f1-score metrics, calculates metrics for each label,
and finds their average weighted by support (the number of true instances for each label). This
alters ”macro” to account for label imbalance; consequently, it can result in an F-score that is
not between precision and recall.
The ROC (Receiver Operating Characteristic) curve is created by plotting the true positive
rate (TPR) or sensitivity against the false positive rate (FPR) i.e. (1-specificity) at different
threshold settings. Varying the decision threshold from its maximal to its minimal value results
in a piecewise linear curve from (0,0) to (1,1), such that each segment has a non-negative slope
(Figure 3). This ROC curve is the main tool used in ROC analysis and in general, can be used to
address a range of problems; however, in our illustrated case where the performance is perfect,
it is just a visual endorsement for the perfect classification and the corresponding AUC (Area
Under the ROC Curve) is its maximum i.e. 1.
Confusion matrix Predicted 0 Predicted 1
Class 0 TN = 1 FP = 0
Class 1 FN = 0 TP = 1
Table 2: Typical confusion matrix with no confusion for perfect identification of cancerous
tumors by either of GNB, SVM, DCT, RFC, LGR and KNN(K=3) where sensitivity, specificity
and precision are all 100%.
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Figure 3: Typical ROC curve of perfecrt classification done by classifiers on most of tumor types.
3. Results
The classification performance on a total of 7971 cancerous WES samples of 22 specific cancers
from TCGA open public database and their corresponding healthy tissues with 4798 WES samples
from the GTEx project were studied in 150+ ML models. Each sample included the normalized
volume of 19627 genes as ppm and the data corresponding to both cancerous and healthy
samples of each organ are separately and directly fed to the machine to do heavy statistical
calculations on the high dimensional data. As result, cancerous samples of all 22 types of
tumors at any stages were correctly identified and separated from their corresponding healthy
samples. The task was accomplished and compared via six supervised ML classifiers i.e. GNB,
SVM, DCT, RFC, LGR and KNN which all showed perfect and in some cases near-perfect
performance as shown in Table 3. In addition, Table 3 contains the results for K-Means as an
unsupervised clustering technique that was applied to evaluate the ability of the algorithm to
distinguish between cancerous and noncancerous cells of different organs as its two main clusters.
Clustering, in general, is different from classification and its algorithms such as K-Means have
their own evaluation techniques. However, we have applied a trick by using classification accuracy
to see how much K-Means clustering to two clusters matches the difference of our interest i.e.
two classes of healthy and cancerous cells of an organ or two classes of two different cancers.
The results were impressive in here too. In some cases, clustering matched 100% with our
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class labels as healthy and cancerous. One tricky point in interpretation of results is that unlike
classification in which the higher the accuracy, the better; in clustering 50% accuracy is the
worst while very high and very low measurements of accuracy are equivalently great because, for
example, an accuracy equal to zero in clustering means that the clustering algorithm, in here K-
Means, has labelled all our class 0 i.e. healthy samples as cluster 1, and all our class 1 labels i.e.
cancers as cluster 0. Therefore, any percentage of accuracy and its counterpart i.e. 100 minus
that percentage are equally good while 50% shows maximum entropy and least match with our
classes and labels. The clustering performance was impressive in several cases, especially that
cancerous and noncancerous cells of Pancreas and Testis were 100% accurately separated into
two distinguished clusters as shown in Table 3. There were also models successfully employed
to further distinguish between different types of an organ’s cancer and two types of cancer
were also separated perfectly. The performance of supervised and unsupervised methods with
different parameters were also studied. For most of changes such as different random seeds,
allocating different volumes of data for training and testing stages and different values for K
in KNN, the consequent changes were negligible as shown in Table 42, Table 43 and Table 44
respectively. The exception was GNB classification performance on LIHC that improved to at
leasr 98% in other settings. However, there are parameters that can change and deteriorate
the results. For example, SVMs with linear and rbf kernels are significantly different: while
linear kernel accomplish the classification perfectly in 19 out of 22 cancer types with three
exceptions that are LGG, COAD and GBM with 99% of accuracy and also f1-score of 0.99, the
results with rbf kernel were not acceptable. An example of LUSC is presented in Table 41 to be
compared with Table 42 that includes the results for SVM with linear kernel. The most common
typical ROC curve and Confusion Matrix for most of our cancer classifications are illustrated in
Figure 3 and Table 2. Therefore, AUC is naturally 1 for most of classifiers in classification of
most of cancerous-healthy samples of specific organs. We also analyzed these ML classifiers’
capability to distinguish between two types of cancers. Whine no longer as 100% perfect results
as before when they classified between healthy and cancerous tissue, yet the results were great
with accuracy and f1-scores above 90% that is better than the previous works we knew about.
The classifiers not only separated samples belonging to two different cancers of brain as well as
lung, but also separated classified well tumors of lung’s LUSC and Bladder’s BLCA which were
previously reported to be very similar and confusing for deep neural network classifiers. [11] For
more details refer to Discussions part of this paper below.
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Accuracy GNB SVM DCT RFC LGR KNN KMeans unsupervised clustering
ACC 1.0 1.0 0.95 1.0 1.0 1.0 0.14=0.86
BLCA 1.0 1.0 0.98 1.0 1.0 1.0 0.64
LGG 0.98 0,99 1.0 0.99 0.99 1.0 0.77
BRCA 1.0 1.0 0.98 1.0 1.0 0.98 0.91
CECS 1.0 1.0 1.0 1.0 1.0 1.0 0.69
LAML 1.0 1.0 1.0 1.0 1.0 1.0 0.44=0.56
COAD 1.0 0.99 1.0 0.99 0.99 0.97 0.18=0.92
ESCA 0.99 1.0 1.0 0.99 1.0 0.98 0.59
GBM 0.99 0.99 0.99 1.0 1.0 1.0 0.72
KIRC 0.98 1.0 0.98 0.98 1.0 0.98 0.77
LIHC 0.92 1.0 0.98 1.0 1.0 0.96 0.08=0.92
LUAD 1.0 1.0 0.99 1.0 1.0 0.94 0.25=0.75
LUSC 1.0 1.0 0.99 1.0 1.0 0.99 0.13=0.87
OV 1.0 1.0 1.0 1.0 1.0 1.0 0.69
PAAD 1.0 1.0 1.0 1.0 1.0 1.0 1.0
PRAD 0.98 1.0 1.0 1.0 1.0 0.98 0.97
READ 1.0 1.0 1.0 1.0 1.0 0.95 0.58
SKCM 1.0 1.0 1.0 1.0 1.0 0.99 0.65
STAD 0.98 1.0 0.97 1.0 1.0 0.97 0.17=0.83
TGCT 1.0 1.0 1.0 1.0 1.0 1.0 0.0=1.0
THCA 1.0 1.0 1.0 1.0 1.0 0.95 0.30=0.70
UCEC 1.0 1.0 1.0 1.0 1.0 1.0 0.69
Table 3: ML Classifiers Accuracy in different tumor type classification.
4. Discussion
Our work facilitates effective applications of ML in medical sciences and resulted in excellent
classification between cancerous and noncancerous cells of 22 most common cancers. In this
work, we did not reduce the dimension of input data and left all the statistical analysis to the ML
system and it could do its job very well and perfectly distinguished the cancerous tumors from
healthy cells in most of the cancer-classifier combinations, and in the remaining pairs almost
perfectly, as shown in Table 3. More details on information summarized in Table 3 can be found
in tables 4-45. We learn from this experiment that we are allowed to reduce the dimension only
after that the famous problem known as ”the curse of dimensionality” has occurred and the
system cannot solve it; otherwise, it is better to leave the calculations to the machines and do
not blindly reduce the dimensions when there is no issue for machine to deal with all available
features and dimensions. For example, in this study, the number of tumor samples ranges
from 77 (ACC) to 1,091 (BRCA) and the number of healthy tissue samples ranges from only 9
(Bladder) and 10 (Cervix) to 1152 (Brain) yet our classifiers can learn from the large distance
between healthy and cancerous bladder tissues in the 19627 dimensional space and correctly
classify all cancerous and healthy tissues very well. For example, after being trained by 6 healthy
samples and 287 Cervical squamous cell carcinoma and endocervical adenocarcinoma samples,
all classifiers i.e. GNB, SVM, DCT, RFC, LGR and KNN (K=5) could classify the remaining
4 healthy samples and 17 cancerous samples 100% precisely and only KNN with K=3 failed in
some cases with overall F-score of 0.99 instead of 1 because of failure of perfect precision in
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one class and recall in the other. Meanwhile, the differences among KNN with different values
for K were negligible. The important point in here is that, indeed, despite having little data to
train, ML classifiers could learn how to classify two groups perfectly thanks to the large number
of dimensions and the differences provided with them. If we decrease the number of features/
dimensions while we also lack huge amount of data i.e. a large number of samples, then we
may have thrown away useful data and cannot train the system well and it cannot classify that
good. It is done by most of researchers before and as a result they get less excellent results.
Our hypothesis is that a large number of features and dimensions can compensate lack of large
number of samples. Imagine, for example, points in 3-dimension space shown as a Cartesian
system. If we have two classes of points that all coordinates of one class are positive numbers
and all coordinates of points in the other class are negative numbers, it will be natural that
any intelligent system including AI systems can quickly learn to separate the two groups even
by a small number of samples. We think that our natural 19K+-dimension space is perfect to
distinguish between healthy samples and impaired cancerous samples after watching dozens of
samples. Even the results after analyzing a few samples of different classes are amazing.
Another fact to notice is that the samples from TCGA and Gtex are diverse representing different
ages, sexes, races and different stages of cancer their statistical details are available on TCGA
and Gtex websites. However, TCGA has not provided information on the stage of GBM, LGG,
OV, PRAD and UCEC tumors but all other tumors are categorized into four different stages
and the classifiers work well on all the data that includes their early satge samples too. Since
our classifiers return perfect results on all of them, therefore, the demographic information do
not have any serious effect on the performance and we do not need to deal with their statistical
details and factors one by one. Another interesting fact is that the problem of separation between
cancerous and noncancerous cells seems to be a linear classification problem because SVM with
linear kernel can classify almost all cancer types from their corresponding healthy tissue cells
perfectly but when SVM was tried with its default kernel i.e. rbf the results were not good. The
difference in results of linear and nonlinear separators imply that the samples of two groups are
naturally separated linearly.
In comparison, as seen in the result tables in appendix/ supplementary materials summarized in
Table 3, SVM with linear kernel, LGR and RFC were almost perfect and slightly superior to other
classifiers and return perfect results for almost all tumor types with a few percentage mistake
for a few remaining cancers, while KNN and DCT were usually inferior; despite the fact that
there were cases that DCT or KNN returned perfectly precise results when others fail to achieve
100%; or KNN as the worst classifier also has always classified tumors and healthy tissues with
no worse than 94% of accuracy. GNB with our most common settings registered record low
accuracy of 92% only on liver cancer (LIHC) which seems to be its outlier result because with
any change, even using less training data i.e. 70% instead of 90% its accuracy was always 98%
or more. The simulations are illustrated in the tables below. GNB particularly acts well when
there are little data available; therefore, should not be ignored when the resources such as data
or computational power are limited.
Finally, we also examined the performance of ML classifiers on several pairs of cancers as shown
in the last table i.e. Table 45. First we tried them to classify between two types of tumors of
Brain cancer i.e. LGG and GBM, and between two types of Lung cancer i.e. LUAD and LUSC,
followed by 2 cancers of Kidney. All of them were separated with accuracy more than 90% which
is amazing because tumors of the same organ are expected to be similar to each other. The
lowest rate of correct classification is for distinguish between Colon Adenocarcinoma (COAD)
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and Rectum Adenocarcinoma (READ) which could be done at the best with about 75% accuracy
by RFC, DFC and KNN which is great because READ and COAD are almost the same things
to that extent that Siegel et. al. [1] have reported the estimated death because of these two
cancers together because in practice, many hospitals are confused by them and count READ as
COAD as one class of cancer that are the same. Therefore, being able to distinguish between
them with more than 70% accuracy even by K-Means unsupervised clustering is hope-giving.
The successful separations between two similar cancers of one organ such as LUAD and LUSC
shown in Table 45 may open a new approach in cancer diagnoses i.e. it may be better to first
detect if the biopsy sample of an organ such as brain or lung is healthy or malignant tumor,
then if it were cancerous, the data can be fed again to the ML classifiers to detect which type
of tumor it is. The benefit of this approach is that in binary classifications between healthy and
cancerous sample of an organ, there is only one option for cancerous cells. If, for example, the
patient suffers from LUSC but the sample is given to a classifier to decide between healthy or
LUAD, it will likely be classified as LUAD. Therefore, it has better to either from the beginning
classify it as healthy or cancerous including all relevant cancers and then distinguish among
cancers or consider the fact and if the sample is recognized as one specific cancer of an organ,
then test it again carefully to classify it correctly among potential cancers of the organ or from
the beginning use a multi-classifier instead of binary classifiers. For detailed info refer to Tables
20, 21, 22 and 23 and the last row of Table 45.
5. Conclusion
These ML systems are trained now and are ready to receive any potential patient’s data to
recognize if the sampled organ is cancerous or not. It can detect the problem in different stages
of cancer accurately; therefore, can be helpful in early diagnosis of cancer. The limitation of
our model is that it needs data of samples taken from organs. Yet most of people do not have
easy access to this level of their own personal genetic data. Thus the next work can be finding
suitable biomarkers in the blood that can detect healthy people and patients only by their blood
samples. Furthermore, the world is realizing the importance of creating databases of single cell
WESs which will result in more accurate cancer studies and the corresponding big data can
also improve ML systems to work perfectly on all cancers hitting each organ of each patient
in personalized medicine which can employ most effective treatments for each person based on
specific differences. Yet our work is one step forward because the best previous work that, to the
best of our knowledge, is done by Sun et. al. [11] implements complicated deep neural networks
that not only is more exhaustive computationally, but also lack clarity as a common feature
of deep neural networks while our simple algorithms run quicker, hit their results with better
precision and recall, works especially better with little data, and the mechanism of action, hence
is not like a black box because the logic of performance is understandable. As an evidence to
our claim, we especially tried the classification of a problematic pair of two different tumor types
where their deep neural network was confused between them i.e. lung’s LUSC and bladder’s
BLCA. Our classifiers again classified these two tumors with more than 90% accuracy where
their deep neural network classifier was confused between them. [11] Most notably, using our
classifiers is more suitable to obtain important features that play the maximum role in the
classification and are the most upregulated or most downregulated genes between cancerous and
noncancerous groups. The latter gives invaluable information both directly as well as indirectly
to be used along with supportive knowledge of pathways which cause cancers.
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Appendix I: Supportive Tables
ML / LAML Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 7
Class 1 1.00 1.00 1.00 18
Micro avg 1.00 1.00 1.00 25
Macro avg 1.00 1.00 1.00 25
Weighted avg 1.00 1.00 1.00 25
Table 4: Perfect identification of Acute Myeloid Leukemia (LAML) by GNB, SVM, DCT, RFC,
LGR, KNN(K=3) all with 100% sensitivity, specificity and precision.
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ML / PAAD Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 19
Class 1 1.00 1.00 1.00 16
Micro avg 1.00 1.00 1.00 35
Macro avg 1.00 1.00 1.00 35
Weighted avg 1.00 1.00 1.00 35
Table 5: Perfect identification of Pancreatic Adenocarcinoma by GNB, SVM, DCT, RFC, LGR,
KNN(K=3) all with 100% sensitivity, specificity and precision.
ML / TGCT Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 22
Class 1 1.00 1.00 1.00 8
Micro avg 1.00 1.00 1.00 30
Macro avg 1.00 1.00 1.00 30
Weighted avg 1.00 1.00 1.00 30
Table 6: Perfect identification of Testicular Germ Cell Tumors by GNB, SVM, DCT, RFC, LGR,
KNN(K=3) all with 100% sensitivity, specificity and precision.
ML / ACC Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 17
Class 1 1.00 1.00 1.00 4
Micro avg 1.00 1.00 1.00 21
Macro avg 1.00 1.00 1.00 21
Weighted avg 1.00 1.00 1.00 21
Table 7: Perfect identification of Adrenal Gland / Adrenocortical Carcinoma by GNB, SVM,
RFC, LGR, KNN(K=3) all with 100% sensitivity, specificity and precision.
DCT /ACC Precision Recall F1-score Support
Class 0 1.00 0.94 0.97 17
Class 1 0.80 1.00 0.89 4
Micro avg 0.95 0.95 0.95 21
Macro avg 0.90 0.97 0.93 21
Weighted avg 0.95 0.95 0.95 21
Table 8: Imperfect identification of Adrenal Gland / Adrenocortical Carcinoma by Decision Tree
Classifier with 95% accuracy.
GNB / Breast Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 22
Class 1 1.00 1.00 1.00 105
Micro avg 1.00 1.00 1.00 127
Macro avg 1.00 1.00 1.00 127
Weighted avg 1.00 1.00 1.00 127
Table 9: Perfect identification of Breast invasive Carcinoma by GNB, SVM, RFC, LGR,
KNN(K=3) all with 100% sensitivity, specificity and precision.
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ML / PRAD Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 9
Class 1 1.00 1.00 1.00 51
Micro avg 1.00 1.00 1.00 60
Macro avg 1.00 1.00 1.00 60
Weighted avg 1.00 1.00 1.00 60
Table 10: Perfect identification of Prostate Adenocarcinoma by SVM, DCT, RFC and LGR all
with 100% sensitivity, specificity and precision.
ML / SKCM Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 85
Class 1 1.00 1.00 1.00 7
Micro avg 1.00 1.00 1.00 92
Macro avg 1.00 1.00 1.00 92
Weighted avg 1.00 1.00 1.00 92
Table 11: Perfect identification of Skin Cutaneous Melanoma by GNB, SVM, DCT, RFC and
LGR all with 100% sensitivity, specificity and precision.
ML / STAD Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 24
Class 1 1.00 1.00 1.00 35
Micro avg 1.00 1.00 1.00 59
Macro avg 1.00 1.00 1.00 59
Weighted avg 1.00 1.00 1.00 59
Table 12: Perfect identification of Stomach Adenocarcinoma by SVM, RFC and LGR all with
100% sensitivity, specificity and precision.
ML / THCA Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 29
Class 1 1.00 1.00 1.00 50
Micro avg 1.00 1.00 1.00 79
Macro avg 1.00 1.00 1.00 79
Weighted avg 1.00 1.00 1.00 79
Table 13: Perfect identification of Skin Cutaneous Melanoma by GNB, SVM, DCT, RFC and
LGR all with 100% sensitivity, specificity and precision.
ML / UCEC Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 7
Class 1 1.00 1.00 1.00 18
Micro avg 1.00 1.00 1.00 25
Macro avg 1.00 1.00 1.00 25
Weighted avg 1.00 1.00 1.00 25
Table 14: Perfect identification of Uterine Corpus Endometrial Carcinoma (UCEC) by GNB,
SVM, DCT, RFC, LGR, KNN(K=3) all with 100% sensitivity, specificity and precision.
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ML / OV Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 3
Class 1 1.00 1.00 1.00 48
Micro avg 1.00 1.00 1.00 51
Macro avg 1.00 1.00 1.00 51
Weighted avg 1.00 1.00 1.00 51
Table 15: Perfect identification of Ovarian serous cystadenocarcinoma (OV) by GNB, SVM,
DCT, RFC, LGR, KNN(K=3) all with 100% sensitivity, specificity and precision.
ML / READ Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 28
Class 1 1.00 1.00 1.00 12
Micro avg 1.00 1.00 1.00 40
Macro avg 1.00 1.00 1.00 40
Weighted avg 1.00 1.00 1.00 40
Table 16: Perfect identification of Rectum adenocarcinoma (READ) by GNB, SVM, DCT, RFC,
LGR all with 100% sensitivity, specificity and precision.
ML / READ Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 1
Class 1 1.00 1.00 1.00 55
Micro avg 1.00 1.00 1.00 56
Macro avg 1.00 1.00 1.00 56
Weighted avg 1.00 1.00 1.00 56
Table 17: Perfect identification of Kidney cancer (KIRC) by SVM and LGR all with 100%
sensitivity, specificity and precision.
ML / READ Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 8
Class 1 1.00 1.00 1.00 160
Micro avg 1.00 1.00 1.00 168
Macro avg 1.00 1.00 1.00 168
Weighted avg 1.00 1.00 1.00 168
Table 18: Perfect identification of Kidney cancer (KIRC) by RFC with 100% sensitivity, specificity
and precision when training with 70% of total data. In this case, GNB, SVM, DCT and LGR
returned 99% accuracy.
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ML / GBM Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 118
Class 1 1.00 1.00 1.00 13
Micro avg 1.00 1.00 1.00 131
Macro avg 1.00 1.00 1.00 131
Weighted avg 1.00 1.00 1.00 131
Table 19: Perfect identification of Brain GBM Glioblastoma multiforme (GBM) by RFC, LGR,
KNN(K=3) all with 100% sensitivity, specificity and precision. GNB, SVM, DCT resulted in
99% accuracy and KMeans 71%; therefore were not shown in this table.
ML / LUAD Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 20
Class 1 1.00 1.00 1.00 61
Micro avg 1.00 1.00 1.00 81
Macro avg 1.00 1.00 1.00 81
Weighted avg 1.00 1.00 1.00 81
Table 20: Perfect identification of Lung Adenocarcinoma (LUAD) by GNB, SVM, RFC, LGR all
with 100% sensitivity, specificity and precision.
ML / LUSC Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 32
Class 1 1.00 1.00 1.00 47
Micro avg 1.00 1.00 1.00 79
Macro avg 1.00 1.00 1.00 79
Weighted avg 1.00 1.00 1.00 79
Table 21: Perfect identification of Lung squamous cell carcinoma (LUSC) by GNB, SVM, RFC,
LGR all with 100% sensitivity, specificity and precision.
DCT / Lung and (LUAD and LUSC) Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 24
Class 1 1.00 1.00 1.00 106
Micro avg 1.00 1.00 1.00 130
Macro avg 1.00 1.00 1.00 130
Weighted avg 1.00 1.00 1.00 130
Table 22: Perfect identification of Lung cancers (both LUAD and LUSC together) by DCT with
100% sensitivity, specificity and precision.
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ML / Lung and (LUAD and LUSC) Precision Recall F1-score Support
Class 0 1.00 0.92 0.96 24
Class 1 0.98 1.00 0.99 106
Micro avg 0.98 0.98 0.98 130
Macro avg 0.99 0.96 0.97 130
Weighted avg 0.98 0.98 0.98 130
Table 23: Imperfect results of identification of Lung cancers (both LUAD and LUSC together)
and Lung healthy tissue by SVM, RFC, LGR all with 98% accuracy (F-score).
SVM, DCT and LGR / ESCA Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 69
Class 1 1.00 1.00 1.00 15
Micro avg 1.00 1.00 1.00 84
Macro avg 1.00 1.00 1.00 84
Weighted avg 1.00 1.00 1.00 84
Table 24: Perfect identification of Esophageal Carcinoma by SVM, DCT and LGR all with 100%
sensitivity, specificity and precision.
SVM, RFC and LGR / LIHC Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 69
Class 1 1.00 1.00 1.00 15
Micro avg 1.00 1.00 1.00 84
Macro avg 1.00 1.00 1.00 84
Weighted avg 1.00 1.00 1.00 84
Table 25: Perfect identification of Liver and Hepatocellular Carcinoma by SVM, DCT and LGR
all with 100% sensitivity, specificity and precision.
RFC / BLCA Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 3
Class 1 1.00 1.00 1.00 247
Micro avg 1.00 1.00 1.00 250
Macro avg 1.00 1.00 1.00 250
Weighted avg 1.00 1.00 1.00 250
Table 26: Perfect identification of Bladder Urothelial Carcinoma by RFC. This particular result
is achieved for train-test slpit on 40% and 60% due to low number of healthy bladder samples.
All other 5 classifeirs also show excellent performance on separation between high-dimensional
WES data of cancerous and noncancerous cells despite having little data to train.
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GNB / LGG Precision Recall F1-score Support
Class 0 0.98 0.99 0.99 106
Class 1 0.98 0.97 0.97 60
Micro avg 0.98 0.98 0.98 166
Macro avg 0.98 0.98 0.98 166
Weighted avg 0.98 0.98 0.98 166
Table 27: Naive Bayes Classification Report on Brain Cancer.
SVM / LGG Precision Recall F1-score Support
Class 0 1.00 0.99 1.00 106
Class 1 0.98 1.00 0.99 60
Micro avg 0.99 0.99 0.99 166
Macro avg 0.99 1.00 0.99 166
Weighted avg 0.99 0.99 0.99 166
Table 28: SVM Classification Report on Brain Cancer.
DCT / LGG Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 106
Class 1 1.00 1.00 1.00 60
Micro avg 1.00 1.00 1.00 166
Macro avg 1.00 1.00 1.00 166
Weighted avg 1.00 1.00 1.00 166
Table 29: Decision Tree Classification Report on Brain Cancer.
RFC / LGG Precision Recall F1-score Support
Class 0 0.98 1.00 0.99 106
Class 1 1.00 0.97 0.98 60
Micro avg 0.99 0.99 0.99 166
Macro avg 0.99 0.98 0.99 166
Weighted avg 0.99 0.99 0.99 166
Table 30: Random Forest Classification Report on Brain Cancer.
LGR / LGG Precision Recall F1-score Support
Class 0 1.00 0.99 1.00 106
Class 1 0.98 1.00 0.99 60
Micro avg 0.99 0.99 0.99 166
Macro avg 0.99 1.00 0.99 166
Weighted avg 0.99 0.99 0.99 166
Table 31: Logistic Regression Classification Report on Brain Cancer.
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KNN / LGG Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 106
Class 1 1.00 1.00 1.00 60
Micro avg 1.00 1.00 1.00 166
Macro avg 1.00 1.00 1.00 166
Weighted avg 1.00 1.00 1.00 166
Table 32: K=3 Nearest Neighbors and K-Means Classification Report on Brain Cancer.
GNB and DCT / Colon Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 30
Class 1 1.00 1.00 1.00 30
Micro avg 1.00 1.00 1.00 60
Macro avg 1.00 1.00 1.00 60
Weighted avg 1.00 1.00 1.00 60
Table 33: Legend (350 words max). Example legend text.
SVM / Colon Precision Recall F1-score Support
Class 0 0.91 0.95 0.93 30
Class 1 0.99 0.98 0.99 30
Micro avg 0.98 0.98 0.98 60
Macro avg 0.95 0.97 0.96 60
Weighted avg 0.98 0.98 0.98 60
Table 34: Legend (350 words max). Example legend text.
RFC / Colon Precision Recall F1-score Support
Class 0 0.97 1.00 0.98 30
Class 1 1.00 0.97 0.98 30
Micro avg 0.98 0.98 0.98 60
Macro avg 0.98 0.98 0.98 60
Weighted avg 0.98 0.98 0.98 60
Table 35: Legend (350 words max). Example legend text.
LGR / Colon Precision Recall F1-score Support
Class 0 1.00 0.97 0.98 30
Class 1 0.97 1.00 0.98 30
Micro avg 0.98 0.98 0.98 60
Macro avg 0.98 0.98 0.98 60
Weighted avg 0.98 0.98 0.98 60
Table 36: Legend (350 words max). Example legend text.
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KNN / Colon Precision Recall F1-score Support
Class 0 1.00 0.93 0.97 30
Class 1 0.94 1.00 0.97 30
Micro avg 0.97 0.97 0.97 60
Macro avg 0.97 0.97 0.97 60
Weighted avg 0.97 0.97 0.97 60
Table 37: Legend (350 words max). Example legend text.
GNB and RFC / ESCA Precision Recall F1-score Support
Class 0 0.99 1.00 0.99 69
Class 1 1.00 0.93 0.97 15
Micro avg 0.99 0.99 0.99 84
Macro avg 0.99 0.97 0.98 84
Weighted avg 0.99 0.99 0.99 84
Table 38: Naive Bayes and Random Forest Classification Report on Esophagus and Esophageal
Carcinoma
GNB / LIHC Precision Recall F1-score Support
Class 0 0.94 1.00 0.97 15
Class 1 1.00 0.97 0.98 33
Micro avg 0.98 0.98 0.98 48
Macro avg 0.97 0.98 0.98 48
Weighted avg 0.98 0.98 0.98 48
Table 39: Performance of GNB on Liver LIHC classification with 0.1 data as testing data and
random seed equal to 42 instead of 0.
ML / LIHC Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 15
Class 1 1.00 1.00 1.00 33
Micro avg 1.00 1.00 1.00 48
Macro avg 1.00 1.00 1.00 48
Weighted avg 1.00 1.00 1.00 48
Table 40: Perfect identification of Liver LIHC cancer by SVM, DCT, RFC, LGR and K=3NN
with 0.1 data as testing data and random seed equal to 42 instead of 0. KMeans clustering was
done with accuracy of 94%
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SVM with rbf kernel / LUSC Precision Recall F1-score Support
Class 0 0.00 0.00 0.00 32
Class 1 0.59 1.00 0.75 47
Micro avg 0.59 0.59 0.59 79
Macro avg 0.30 0.50 0.37 79
Weighted avg 0.35 0.59 0.44 79
Table 41: The performance of SVM classifier on Lung and LUSC (Lung Squamous Cell Car-
cinoma), when SVM using rbf as kernel with no correct detection of healthy cells, instead of
linear kernel that resulted in 100% accurate classification of both classes, shows that the nature
of separation between healthy and cancerous cells is linear.
GNB, SVM, RFC, LGR / LUSC Precision Recall F1-score Support
Class 0 1.00 1.00 1.00 32
Class 1 1.00 1.00 1.00 47
Micro avg 1.00 1.00 1.00 79
Macro avg 1.00 1.00 1.00 79
Weighted avg 1.00 1.00 1.00 79
Table 42: Perfect identification of Lung squamous cell carcinoma by GNB, SVM, RFC, LGR
all with 100% sensitivity, specificity and precision. Even KNN(K=3) returned the same perfect
result when using random seed 42 instead of 0 that returned 0.98 that is also for DCT.
Accuracy based on training data GNB SVM DCT RFC LGR KNN KMeans unsupervised clustering
0.1 0.96 0.94 0.96 0.98 0.96 0.94 0.92
0.3 0.98 0.99 0.97 0.99 0.99 0.95 0.93
0.5 0.99 0.98 0.96 0.99 0.99 0.95 0.94
0.7 0.99 0.99 0.99 1.0 1.0 0.94 0.93
0.9 0.92 1.0 0.98 1.0 1.0 0.96 0.92
Table 43: The effect of different portion of LIHC data as training data volume on F-
score/accuracy of different classifiers.
KNN F-score on Liver and LIHC Lung and LUSC BLCA and LUSC cancers together
K = 1 0.94 1.0 0.85
K = 3 0.96 0.98 0.89
K = 5 0.96 0.99 0.91
K = 7 0.96 0.99 0.91
K = 13 0.96 0.99 0.85
K = 39 0.96 0.96 0.84
Table 44: Performance analysis by F-score accuracy of KNN on Liver LIHC classification with
0.1 data as testing data (10 Class 0 and 38 Class 1 samples) and random seed equal to 0 but
with different values for K.
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ML / 2 Cancers GNB SVM DCT RFC LGR KNN KMeans unsupervised clustering
Lung LUAD and LUSC 0.94 0.90 0.94 0.95 0.91 0.88 0.38=0.62
Brain GBM and LGG 0.94 0.98 0.98 1.0 0.94 0.92 0.75
Colon COAD and READ 0.61 0.68 0.74 0.76 0.68 0.74 0.71
Kidney KIRC and KIRP 0.91 0.91 0.89 0.93 0.91 0.88 0.57
Lung LUSC and Bladder BLCA 0.97 0.98 0.98 0.99 1.0 0.91 0.68
Table 45: The F-score/accuracy performance of different ML classifiers on 2 types of cancerous
samples.
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